FNBP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.327600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.323400E-01
Normal-vs-Stage2
4.434000E-01
Normal-vs-Stage3
3.025200E-01
Normal-vs-Stage4
5.419200E-01
Stage1-vs-Stage2
8.755000E-01
Stage1-vs-Stage3
4.688500E-02
Stage1-vs-Stage4
2.105800E-01
Stage2-vs-Stage3
9.306200E-02
Stage2-vs-Stage4
4.130600E-01
Stage3-vs-Stage4
1.159900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.393800E-01
Normal-vs-AfricanAmerican
3.706400E-01
Normal-vs-Asian
3.992000E-01
Caucasian-vs-AfricanAmerican
3.529400E-01
Caucasian-vs-Asian
4.656800E-01
AfricanAmerican-vs-Asian
7.264400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.357400E-01
Normal-vs-Female
4.303600E-01
Male-vs-Female
8.546000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.966400E-01
Normal-vs-Age(41-60Yrs)
4.718800E-01
Normal-vs-Age(61-80Yrs)
4.221000E-01
Normal-vs-Age(81-100Yrs)
3.791600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.352400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.041200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.567000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.491580E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.662300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.420200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.194200E-01
Normal-vs-Daily Drinker
3.851800E-01
Normal-vs-Weekly Drinker
4.221000E-01
Normal-vs-Occasional Drinker
4.637800E-01
Normal-vs-Social Drinker
4.816800E-01
Non Drinker-vs-Daily Drinker
4.568200E-01
Non Drinker-vs-Weekly Drinker
9.913000E-01
Non Drinker-vs-Occasional Drinker
4.721600E-01
Non Drinker-vs-Social Drinker
3.279200E-01
Daily Drinker-vs-Weekly Drinker
5.357200E-01
Daily Drinker-vs-Occasional Drinker
1.813600E-01
Daily Drinker-vs-Social Drinker
1.063010E-01
Weekly Drinker-vs-Occasional Drinker
5.725200E-01
Weekly Drinker-vs-Social Drinker
4.281600E-01
Occasional Drinker-vs-Social Drinker
8.149000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.449170E-01
Normal-vs-Grade 2
7.281600E-03
Normal-vs-Grade 3
1.575600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.642400E-01
Grade 1-vs-Grade 3
1.711770E-01
Grade 1-vs-Grade 4
1.449170E-01
Grade 2-vs-Grade 3
9.921400E-01
Grade 2-vs-Grade 4
7.281600E-03
Grade 3-vs-Grade 4
1.575600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.133600E-01
Normal-vs-NonDiabetic
4.290600E-01
Diabetic-vs-NonDiabetic
6.345600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.548800E-01
Normal-vs-NoPancreatitis
4.152800E-01
Pancreatitis-vs-NoPancreatitis
5.100400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.446600E-01
Normal-vs-N1
4.321800E-01
N0-vs-N1
7.330800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.699600E-01
Normal-vs-TP53-NonMutant
4.503400E-01
TP53-Mutant-vs-TP53-NonMutant
6.731000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
